Abrocitinib for atopic dermatitis: a step forward-Reference-Cited by-同舟云学术

Abrocitinib for atopic dermatitis: a step forward

Published:2020-07 Issue:10246 Volume:396 Page:215-217
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Weidinger Stephan,Schreiber Stefan

Publisher

Elsevier BV

Subject

General Medicine

Reference12 articles.

1. Atopic dermatitis;Weidinger;Nat Rev Dis Primers,2018

2. Epidemiology of atopic dermatitis in adults: results from an international survey;Barbarot;Allergy,2018

3. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany;Heratizadeh;J Eur Acad Dermatol Venereol,2019

4. Dupilumab for atopic dermatitis;Strowd;Lancet,2017

5. Janus kinases to jakinibs: from basic insights to clinical practice;Gadina;Rheumatology,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses;Frontiers in Immunology;2024-02-23

2. Unveiling abrocitinib: A thorough examination of the 2022 USFDA-approved treatment for atopic dermatitis (AD);Medicine in Drug Discovery;2023-12

3. Therapeutic potential of microneedles based delivery systems for the management of atopic dermatitis;Journal of Drug Delivery Science and Technology;2023-06

4. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer;Signal Transduction and Targeted Therapy;2023-05-19

5. Oral Janus kinase inhibitors for atopic dermatitis;Annals of Allergy, Asthma & Immunology;2023-05